Cover Image

Indirect treatment comparison of lurbinectedin versus other second-line treatments for small-cell lung cancer

Aim: Compare lurbinectedin versus other second-line (2L) small-cell lung cancer (SCLC) treatments. Methods: An unanchored matching-adjusted indirect comparison connected the platinum-sensitive SCLC cohort of a single-arm lurbinectedin trial to a network of three randomized controlled trials (oral an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Raj Hanvesakul (Author), Badri Rengarajan (Author), Navit Naveh (Author), Anne Boccuti (Author), Julie E Park (Author), Adekemi Adeyemi (Author), Clyde Caisip (Author), Jeroen P Jansen (Author), Florence R Wilson (Author)
Format:	Book
Published:	Becaris Publishing Limited, 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Post-marketing safety evaluation of lurbinectedin: a pharmacovigilance analysis based on the FAERS database
by: Zhao Li, et al.
Published: (2024)

Exceptional response to lurbinectedin and irinotecan in -mutated platinum-resistant ovarian cancer patient: a case report
by: Laura Cortesi, et al.
Published: (2022)

Second-line treatment options in hepatocellular carcinoma
by: Donatella Marino, et al.
Published: (2019)

Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models
by: María Virtudes Céspedes, et al.
Published: (2016)

Dolutegravir for second-line treatment: Programmatic implications of new evidence
by: Ying Zhao, et al.
Published: (2022)

FOLFIRI as second-line treatment of metastatic biliary tract cancer patients
by: Rafael Caparica, et al.
Published: (2019)

Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment
by: Bo Hyun Kim, et al.
Published: (2021)

Long-term outcomes of second-line antiretroviral treatment in an adult and adolescent cohort in Myanmar
by: Nang Thu Thu Kyaw, et al.
Published: (2017)

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
by: Channing J Paller, et al.
Published: (2011)

Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea
by: Tremblay G, et al.
Published: (2016)

Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia
by: N. A. Avxentyev, et al.
Published: (2018)

METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY
by: N. A. Avxentyev, et al.
Published: (2016)

Comparison of Treatment Outcomes among Second-Line Antiretroviral Regimens in HIV/AIDS Patient
by: Winda Dwi Puspitasari, et al.
Published: (2018)

Risk Factors and Treatment Outcome Analysis Associated with Second-Line Drug-Resistant Tuberculosis
by: Muralidhar Aaina, et al.
Published: (2021)

OUR EXPERIENCE WITH TOPOTECAN AS SECOND- LINE TREATMENT OF PATIENTS WITH RELAPSED SMALL CELL LUNG CANCER
by: Deyan Davidov
Published: (2010)

Cost containment by peer prior authorization program for second line treatment in patients with retinal disease
by: Amir Rosenblatt, et al.
Published: (2021)

Is pulpotomy obsolete? A clinical study on the success rates of indirect pulp capping and pulpotomy in the treatment of deep dentinal caries in primary second molars
by: K B Vidya, et al.
Published: (2015)

Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa
by: Idah Mokhele, et al.
Published: (2021)

European Registry on <em>Helicobacter pylori</em> Management: Effectiveness of First and Second-Line Treatment in Spain
by: María Caldas, et al.
Published: (2020)

Anakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment
by: Anton J, et al.
Published: (2011)

Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy
by: Gerald HJ Mickisch, et al.
Published: (2011)

Treatment of Moya Moya disease using indirect surgery technique
by: Cezary Grochowski, et al.
Published: (2016)

Indirect veneer treatment of anterior maxillary teeth with enamel hypoplasia
by: Devi Eka Juniarti
Published: (2010)

Treatment of Moya Moya disease using indirect surgery technique
by: Cezary Grochowski, et al.
Published: (2016)

Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
by: Ian N Bruce, et al.
Published: (2022)

HER2-positive metastatic cervical cancer responsive to first and second-line treatment: A case report
by: Dylan Fortman, et al.
Published: (2020)

Cost-effectiveness analysis of pembrolizumab vs. chemotherapy as second-line treatment for advanced esophageal carcinoma in the United States
by: Jia Hu, et al.
Published: (2022)

TKI or TKI combined with PD-1 inhibitors as second-line treatment for HCC patients after sorafenib failure
by: Jin Lei, et al.
Published: (2022)

Direct and Indirect Contributions of Three Aspects of Morphological Knowledge to Second Language Reading Comprehension
by: Junko Yamashita, et al.
Published: (2024)

Vicenin-2 inhibits Wnt/β-catenin signaling and induces apoptosis in HT-29 human colon cancer cell line
by: Yang D, et al.
Published: (2018)

An indirect veneer technique for simple and esthetic treatment of anterior hypoplastic teeth
by: Amit Khatri, et al.
Published: (2010)

Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome
by: Christina Deligianni, et al.
Published: (2023)

Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug-Drug Interaction Study
by: Irene Moreno, et al.
Published: (2024)

Second Line Treatment of Non-Small Cell Lung Cancer: Clinical; Pathological and Molecular Aspects of Novel Promising Drugs
by: Umberto Malapelle
Published: (2017)

Angiographic Embolization of a Postpartum Vulvovaginal Hematoma in a Patient with Situs Inversus Totalis: An Effective Second-Line Treatment
by: Elias M. Dahdouh, et al.
Published: (2013)

Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment
by: Siphamandla B. Gumede, et al.
Published: (2020)

Economic evaluation of tislelizumab versus chemotherapy as second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China
by: Fenghao Shi, et al.
Published: (2022)

Cost-Effectiveness Analysis of Camrelizumab Versus Chemotherapy as Second-Line Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma
by: Hongfu Cai, et al.
Published: (2021)

When first line treatment of neonatal infection is not enough: blood culture and resistance patterns in neonates requiring second line antibiotic therapy in Bangui, Central African Republic
by: Andrea Nebbioso, et al.
Published: (2021)

Materials used for indirect pulp treatment in primary teeth: a mixed treatment comparisons meta-analysis
by: Pablo Silveira dos Santos, et al.
Published: (2017)